News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,970 Results
Type
Article (14916)
Company Profile (299)
Press Release (266749)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79841)
Career Advice (163)
Deals (13337)
Drug Delivery (39)
Drug Development (50706)
Employer Resources (31)
FDA (5840)
Job Trends (5170)
News (145094)
Policy (10072)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (920)
Accelerated approval (20)
Adcomms (14)
Allergies (85)
Alliances (21761)
ALS (126)
Alzheimer's disease (1037)
Antibody-drug conjugate (ADC) (247)
Approvals (6039)
Artificial intelligence (268)
Autoimmune disease (123)
Automation (9)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (102)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (46)
Breast cancer (349)
Cancer (3172)
Cardiovascular disease (240)
Career advice (148)
Career pathing (8)
CAR-T (224)
CDC (5)
Cell therapy (578)
Cervical cancer (14)
Clinical research (43738)
Collaboration (1172)
Company closure (2)
Compensation (605)
Complete response letters (42)
COVID-19 (1102)
CRISPR (89)
C-suite (571)
Cystic fibrosis (112)
Data (4377)
Denatured (15)
Depression (96)
Diabetes (257)
Diagnostics (1383)
Digital health (13)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (196)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (219)
Earnings (31694)
Editorial (27)
Employer branding (4)
Employer resources (29)
Events (51729)
Executive appointments (631)
FDA (7616)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (993)
Gene editing (186)
Generative AI (22)
Gene therapy (498)
GLP-1 (507)
Government (1149)
Grass and pollen (3)
Guidances (166)
Healthcare (6613)
HIV (19)
Huntington's disease (44)
IgA nephropathy (75)
Immunology and inflammation (196)
Immuno-oncology (43)
Indications (73)
Infectious disease (1212)
Inflammatory bowel disease (160)
Inflation Reduction Act (10)
Influenza (40)
Intellectual property (171)
Interviews (18)
IPO (7346)
IRA (13)
Job creations (867)
Job search strategy (130)
JPM (40)
Kidney cancer (9)
Labor market (24)
Layoffs (244)
Leadership (10)
Legal (1401)
Liver cancer (41)
Longevity (11)
Lung cancer (426)
Lymphoma (252)
Machine learning (24)
Management (7)
Manufacturing (381)
MASH (133)
Medical device (2667)
Medtech (2676)
Mergers & acquisitions (6623)
Metabolic disorders (735)
Multiple sclerosis (107)
NASH (13)
Neurodegenerative disease (235)
Neuropsychiatric disorders (70)
Neuroscience (1975)
Neurotech (1)
NextGen: Class of 2026 (2034)
Non-profit (867)
Now hiring (31)
Obesity (334)
Opinion (125)
Ovarian cancer (132)
Pain (103)
Pancreatic cancer (165)
Parkinson's disease (233)
Partnered (12)
Patents (310)
Patient recruitment (347)
Peanut (44)
People (26700)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15497)
Phase 2 (20322)
Phase 3 (12834)
Pipeline (3398)
Policy (91)
Postmarket research (853)
Preclinical (6544)
Press Release (30)
Prostate cancer (148)
Psychedelics (50)
Radiopharmaceuticals (241)
Rare diseases (663)
Real estate (1448)
Recruiting (12)
Regulatory (9935)
Reports (20)
Research institute (973)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (17)
Schizophrenia (125)
Series A (184)
Series B (140)
Service/supplier (1)
Sickle cell disease (79)
Special edition (19)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2006)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (342)
Venture capital (69)
Weight loss (174)
Women's health (27)
Worklife (2)
Date
Today (77)
Last 7 days (282)
Last 30 days (1195)
Last 365 days (17799)
2026 (2058)
2025 (18098)
2024 (20543)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23357)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (154)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18278)
Australia (3114)
California (7162)
Canada (1864)
China (784)
Colorado (250)
Connecticut (257)
Delaware (239)
Europe (39230)
Florida (916)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (398)
India (36)
Indiana (162)
Iowa (8)
Japan (230)
Kansas (81)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (741)
Massachusetts (5641)
Michigan (110)
Minnesota (251)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (33)
New Hampshire (21)
New Jersey (1664)
New Mexico (13)
New York (1780)
North Carolina (841)
North Dakota (6)
Northern California (3530)
Ohio (180)
Oklahoma (11)
Oregon (24)
Pennsylvania (1291)
Puerto Rico (9)
Rhode Island (26)
South America (215)
South Carolina (9)
Southern California (2838)
Tennessee (40)
Texas (923)
United States (23604)
Utah (97)
Virginia (139)
Washington D.C. (37)
Washington State (594)
West Virginia (1)
Wisconsin (46)
281,970 Results for "tersera therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ESTEVE to Acquire TerSera Therapeutics’ Infusion Specialty Therapies Business Unit, Expanding U.S. Presence
January 13, 2026
·
11 min read
Press Releases
TerSera Therapeutics to Present Real-World Data on Intrathecal Ziconotide (PRIALT®) Prescription Patterns at ASPN 2025
July 18, 2025
·
8 min read
Press Releases
MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®
October 23, 2024
·
10 min read
Press Releases
TerSera® Presents New Real-World Evidence on Treatment Outcomes of Goserelin (ZOLADEX®) in Women with Breast Cancer at the 2024 San Antonio Breast Cancer Symposium
December 12, 2024
·
10 min read
Press Releases
TerSera® Presents Real-World Evidence on Treatment Patterns of Goserelin (ZOLADEX®) in Women with Breast Cancer at the 2024 American Society of Clinical Oncology (ASCO) Quality Care Symposium
October 2, 2024
·
9 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
BioMidwest
TerSera® to sponsor “NET Cancer Health Storylines” digital platform to support patients suffering from Carcinoid Syndrome Diarrhea
TerSera Therapeutics announced a new sponsorship with the Carcinoid Cancer Foundation and Alira Health to expand and optimize a holistic patient journey digital platform for patients with Neuroendocrine Tumors and Carcinoid Syndrome.
December 7, 2022
·
7 min read
BioMidwest
TerSera® Announces Publication Of Real-World Study On Xermelo® (Telotristat Ethyl) In Patients With Carcinoid Syndrome Diarrhea
TerSera Therapeutics LLC announced today the online publication of the TELEPRO-II study in the Journal of Cancer Management and Research.
October 27, 2021
·
7 min read
Deals
Lexicon Pharmaceuticals Completes the Sale of XERMELO to TerSera Therapeutics
Lexicon Pharmaceuticals, Inc. announced the completion of the sale of Lexicon’s rights, title and interest in XERMELO® to TerSera Therapeutics LLC.
September 8, 2020
·
3 min read
Press Releases
vTv Therapeutics to Participate in Upcoming Investor Conferences
February 13, 2026
·
1 min read
1 of 28,197
Next
